Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases

• Format: eBook
• Language: English
• Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Subjects: Medicine; AAV; autoantibodies; biomarker; budesonide; cholestatic diseases; chronic hepatitis B; cirrhosis; DAA; deletions; farnesoid X receptor; fatty liver; females; fibrates; fibrosis score; FXR agonists; gender; gene therapy; genotoxicity; glycoprotein gp210; HBX 3' end region; HCV; hepatic steatosis; hepatitis B virus; hepatitis B X open reading frame; hepatocellular carcinoma; insertions; KLHL12 peptide; liver; liver fibrosis; metabolism; miR-125b; mitochondria; n/a; NAFLD; NASH; next-generation sequencing; non-alcoholic fatty liver disease; nucleoporin p62; nucleos(t)ide analogs; obeticholic acid; obeticholic acid (OCA); PBC; PFIC; PPAR agonists; primary biliary cholangitis; quasispecies; radiofrequency ablation; RUNX1; side effect; systems biology; transarterial chemoembolization; transient hepatic elastography; type 2 diabetes mellitus; ursodeoxycholic acid; ursodeoxycholic acid (UDCA)
• Online Access: Open Access: DOAB: description of the publication; Open Access: DOAB, download the publication
• Physical Description: 1 online resource (190 p.)
• ISBN: 9783036577388; 9783036577395; books978-3-0365-7738-8
• Access: Open Access

The Special Issue of Biomedicines, entitled "Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases," presents cutting-edge research findings, innovations, and insights into a wide range of topics related to the hepatobiliary system, such as the molecular mechanisms underlying disease pathogenesis, diagnostic advancements, novel therapeutic approaches, and prevention strategies. The Special Issue comprises seven original articles and four review articles regarding NAFLD, primary biliary cholangitis (PBC), hepatitis B and C, and hepatocellular carcinoma (HCC).